Immunic GAAP EPS of -$0.20 misses by $0.03
Source: SeekingAlpha
2025-08-07 07:58:45 ET
More on Immunic
- Immunic Post-Readout: Reiterating Strong Buy As Big Drop Appears Unwarranted
- Immunic shares fall 12% after pricing of $65 million underwritten public offering to fund trials
- Immunic launches public offering of warrants to fund clinical trials; shares down
- Seeking Alpha’s Quant Rating on Immunic
- Historical earnings data for Immunic
Read the full article on Seeking Alpha
For further details see:
Immunic GAAP EPS of -$0.20 misses by $0.03
Immunic Inc.
NASDAQ: IMUX
IMUX Trading
-15.16% G/L:
$1.175 Last:
4,026,747 Volume:
$1.39 Open:
IMUX Latest News
March 10, 2026 06:30:00 am
Immunic Announces Grant of Key European Patent Protecting Relevant Dosing Regimens for Vidofludimus Calcium
February 26, 2026 06:30:00 am
Immunic, Inc. Reports Year-End 2025 Financial Results and Provides Corporate Update
February 17, 2026 04:05:00 pm
Immunic Announces Closing of Oversubscribed Private Placement Financing
IMUX Stock Data
$99,716,036
88,288,987
2.21%
24
N/A
Biotechnology & Life Sciences
Healthcare
US
New York
